Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England.
The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.

3.7
See rating distribution
ICO rating reflects the amount of information available about a project and does not indicate its quality. Therefore, ICO rating must not be taken as investment advice

Overview

Country United Kingdom
Type ICO
Z
Zain Rana
CEO, CO-FOUNDER
NOT VERIFIED
Member of this ICO only
A
Ahmed Ashour
COO, CO-FOUNDER
NOT VERIFIED
Member of this ICO only
O
Oleh Anfimov
BLOCKCHAIN DEVELOPER
NOT VERIFIED
Member of this ICO only
O
Oleh Pashchenko
BLOCKCHAIN DEVELOPER
NOT VERIFIED
Member of this ICO only
T
Tyra Ho
DIGITAL MARKETER
NOT VERIFIED
Member of this ICO only
E
Essam Elmir
STRATEGY ADVISOR
NOT VERIFIED
Member of this ICO only
3.7
See rating distribution
ICO rating reflects the amount of information available about a project and does not indicate its quality. Therefore, ICO rating must not be taken as investment advice

Overview

Country United Kingdom
Type ICO

Financial information

Platform Ethereum
Whitelist/KYC Not needed

Interest

Alexa rank 3,776,460 th
Twitter followers 6,404
Promotional video views 625
Similar icos
Disclaimer

TrackICO does not encourage investing in any ICOs published on the platform. Make sure to do your own thorough research before putting money into Initial Coin Offerings. All content on TrackICO is meant to be used for information purposes only, and should not be taken as financial or investment advice.